Explore
Helicobacter pylori
0 Ungluers have
Faved this Work
Login to Fave
The discovery of Helicobacter pylori by Marshall and Warren in 1984, a gram-negative, spiral bacterium isolated from the gastric mucosa, revolutionized the treatment of gastric diseases, leading to the inclusion of antibiotic therapy in individuals diagnosed with ulcers and gastritis. To survive in the inhospitable environment of the stomach, H. pylori has acquired molecules capable of minimizing acidity and evading the host's immune system over its evolutionary history. Interaction with the host's gastric mucosa is usually focal and can cause various pathologies, depending on the genetic characteristics of H. pylori . Once detected in the gastric or duodenal mucosa, antibiotic therapy is indicated, with the challenge of obtaining antibiotics that maintain activity in the acidic environment. Furthermore, as with all bacteria, it is important to investigate the occurrence of H. pylori resistant to antibiotics used in therapeutic regimens. Therefore, this book will address topics involving H. pylori , including diagnostic methods, pathogenicity mechanisms, including interactions with herpesviruses, and antibiotic therapy options.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 2 times via unglue.it ebook links.
- 2 - pdf (CC BY) at intech-files.s3.amazonaws.com.
Keywords
- Medical / Microbiology
- thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKF Pathology::MKFM Medical microbiology and virology
Links
DOI: 10.5772/intechopen.1008036Editions